Table 2 Proportions of Disease Groups Obtained from the Algorithm’s Top-1 Prediction by Continent and Countries
From: Planet-wide performance of a skin disease AI algorithm validated in Korea
Location | Total Queries | Benigns | Allergies | Infections | Malignancies | Estimated FP |
|---|---|---|---|---|---|---|
Korea, Republic of | 382,602 | 249,395 (65.2%, CI 65.0–65.3%) | 27,069 (7.1%, CI 7.0–7.2%) | 27,570 (7.2%, CI 7.1–7.3%) | 7957 (2.1%, CI 2.0–2.1%) | 3.1% (CI 3.0–3.2%) |
Italy | 151,574 | 79,350 (52.4%, CI 52.1–52.6%) | 16,232 (10.7%, CI 10.6–10.9%) | 15,258 (10.1%, CI 9.9–10.2%) | 3550 (2.3%, CI 2.3–2.4%) | 4.3% (CI 4.1–4.4%) |
United States | 105,233 | 40,957 (38.9%, CI 38.6–39.2%) | 14,888 (14.1%, CI 13.9–14.4%) | 13,252 (12.6%, CI 12.4–12.8%) | 2953 (2.8%, CI 2.7–2.9%) | 6.7% (CI 6.5–7.0%) |
Germany | 100,285 | 51,000 (50.9%, CI 50.5–51.2%) | 12,027 (12.0%, CI 11.8–12.2%) | 10,413 (10.4%, CI 10.2–10.6%) | 1935 (1.9%, CI 1.8–2.0%) | 3.7% (CI 3.5–3.8%) |
France | 68,408 | 30,430 (44.5%, CI 44.1–44.9%) | 10,399 (15.2%, CI 14.9–15.5%) | 8,538 (12.5%, CI 12.2–12.7%) | 1,393 (2.0%, CI 1.9–2.1%) | 4.4% (CI 4.2–4.6%) |
Russian Federation | 64,997 | 17,925 (27.6%, CI 27.2–27.9%) | 13,723 (21.1%, CI 20.8–21.4%) | 10,653 (16.4%, CI 16.1–16.7%) | 619 (1.0%, CI 0.9–1.0%) | 3.3% (CI 3.1–3.6%) |
Spain | 56,347 | 27,667 (49.1%, CI 48.7–49.5%) | 6210 (11.0%, CI 10.8–11.3%) | 5383 (9.6%, CI 9.3–9.8%) | 1142 (2.0%, CI 1.9–2.1%) | 4.0% (CI 3.7–4.2%) |
Brazil | 54,974 | 18,305 (33.3%, CI 32.9–33.7%) | 8063 (14.7%, CI 14.4–15.0%) | 7642 (13.9%, CI 13.6–14.2%) | 841 (1.5%, CI 1.4–1.6%) | 4.4% (CI 4.1–4.7%) |
United Kingdom | 54,028 | 23,692 (43.9%, CI 43.4–44.3%) | 6939 (12.8%, CI 12.6–13.1%) | 6127 (11.3%, CI 11.1–11.6%) | 1479 (2.7%, CI 2.6–2.9%) | 5.9% (CI 5.6–6.2%) |
Hungary | 47,937 | 21,224 (44.3%, CI 43.8–44.7%) | 7418 (15.5%, CI 15.2–15.8%) | 6168 (12.9%, CI 12.6–13.2%) | 759 (1.6%, CI 1.5–1.7%) | 3.5% (CI 3.2–3.7%) |
Europe | 810,181 | 376,874 (46.5%, CI 46.4–46.6%) | 108,783 (13.4%, CI 13.4–13.5%) | 93,324 (11.5%, CI 11.4–11.6%) | 15,073 (1.9%, CI 1.8–1.9%) | 3.8% (CI 3.8–3.9%) |
Asia | 533,106 | 295,687 (55.5%, CI 55.3–55.6%) | 54,081 (10.1%, CI 10.1–10.2%) | 53,415 (10.0%, CI 9.9–10.1%) | 9,714 (1.8%, CI 1.8–1.9%) | 3.2% (CI 3.1–3.2%) |
North America | 170,948 | 65,039 (38.0%, CI 37.8–38.3%) | 24,904 (14.6%, CI 14.4–14.7%) | 21,972 (12.9%, CI 12.7–13.0%) | 4466 (2.6%, CI 2.5–2.7%) | 6.4% (CI 6.2–6.6%) |
South America | 96,373 | 31,100 (32.3%, CI 32.0–32.6%) | 15,339 (15.9%, CI 15.7–16.1%) | 14,274 (14.8%, CI 14.6–15.0%) | 1,344 (1.4%, CI 1.3–1.5%) | 4.1% (CI 3.9–4.4%) |
Africa | 48,483 | 10,858 (22.4%, CI 22.0–22.8%) | 7485 (15.4%, CI 15.1–15.8%) | 8284 (17.1%, CI 16.8–17.4%) | 460 (0.9%, CI 0.9–1.0%) | 4.1% (CI 3.7–4.4%) |
Oceania | 31,941 | 14,943 (46.8%, CI 46.2–47.3%) | 3611 (11.3%, CI 11.0–11.7%) | 2739 (8.6%, CI 8.3–8.9%) | 549 (1.7%, CI 1.6–1.9%) | 3.5% (CI 3.3–3.8%) |
Total | 1,691,032 | 794,501 (47.0%, CI 46.9–47.1%) | 214,203 (12.7%, CI 12.6–12.7%) | 194,008 (11.5%, CI 11.4–11.5%) | 31,606 (1.9%, CI 1.8–1.9%) | 3.8% (CI 3.8–3.9%) |
